Quarterly report pursuant to Section 13 or 15(d)

EQUITY

v3.20.2
EQUITY
 6 Months Ended
Jun. 30, 2020
Equity [Abstract]  
Equity EQUITY
Accumulated Other Comprehensive Loss
The following table presents changes in the components of AOCI, net of taxes, for the six months ended June 30, 2020:
Loss on Cash Flow Hedge  Foreign Currency Items Total
(in thousands)
Balance at December 31, 2019 $ —    $ (145,713)   $ (145,713)  
Other comprehensive loss before reclassifications
 (36,596)   (62,849)   (99,445)  
Amount reclassified from AOCI 1,353    —    1,353   
Net other comprehensive loss (35,243)   (62,849)   (98,092)  
Balance at June 30, 2020 $ (35,243)   $ (208,562)   $ (243,805)  
See Note 7—Fair Value Measurements for further discussion and disclosure of the fair value of our interest rate swap that has been designated as a cash flow hedge.
Earnings Per Share
Basic net income (loss) per common share is computed by dividing the net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period. The calculation of diluted net income (loss) per common share includes the effects of the assumed exercise of any outstanding stock options, the assumed vesting of shares of restricted and deferred stock awards and the assumed conversion of our convertible senior notes, where dilutive.
The following table sets forth the computation of weighted average common shares outstanding:

Three Months Ended
June 30,		 Six Months Ended
June 30,
2020 2019 2020 2019
(in thousands)
Weighted average common shares—basic 211,693,923    209,998,048    211,371,109    209,456,196   
Effect of dilutive securities:
    Stock options and restricted stock —    9,636,873    —    9,651,155   
    Convertible senior notes —    342,691    —    —   
Weighted average common shares—diluted 211,693,923    219,977,612    211,371,109    219,107,351   

The following table shows securities excluded from the calculation of diluted net income (loss) per common share because such securities are anti-dilutive:
Three Months Ended
June 30,		 Six Months Ended
June 30,
2020 2019 2020 2019
Options to purchase shares of common stock 10,197,507    486,849    10,197,507    486,849   
Restricted stock and deferred stock—unvested 5,150,289    1,326,480    5,150,289    1,365,825   
Conversion shares related to the convertible senior notes 11,864,035    8,085,275    11,864,035    8,085,275   
Number of anti-dilutive potentially issuable shares excluded from diluted common shares outstanding 27,211,831    9,898,604    27,211,831    9,937,949